Infection-related mortality and infection control practices in childhood acute myeloid leukemia in a limited resource setting: Experience with the Indonesian national protocol
PDF
XML

Keywords

Indonesia
acute myeloid leukemia
infection
mortality
resource limited settings
hospitals

How to Cite

Supriyadi, E., Purwanto, I., Widiastuti, Z., Armytasari, I., Sandi, S., Ardianto, B., & Kaspers, G. J. L. (2024). Infection-related mortality and infection control practices in childhood acute myeloid leukemia in a limited resource setting: Experience with the Indonesian national protocol. Belitung Nursing Journal, 10(2), 185–191. https://doi.org/10.33546/bnj.3139
Crossref
Scopus
Google Scholar

Link to Google Scholar

Accepted for publication: 2024-01-28
Peer reviewed: Yes

Share on Share on Facebook Tweet This Share on LinkedIn Share on reddit Send email

Abstract

Background: In resource-limited settings, addressing infections remains a substantial challenge in the management of children with Acute Myeloid Leukemia (AML). In Indonesia, infection-related mortality (IRM) is thought to be high compared to high-income countries. However, there has been no previous study of infection profile and IRM in Indonesian patients with AML.

Objective: This study aimed to describe infections and IRM in children with AML treated according to the Indonesian National AML protocol and to describe the implementation of infection control practices in resource-limited settings.

Methods: This retrospective observational study used secondary data from the medical records of pediatric patients with AML treated with the National Protocol at Dr. Sardjito Hospital, Yogyakarta, Indonesia, from April 2012 to September 2018. Essential patient characteristics, time of IRM, and cause of death were recorded, and infection control practices were observed. Data were analyzed using descriptive statistics.

Results: 113 patients with AML were treated with the National protocol, and 83 met the inclusion criteria. Infections occurred in 69 (83%) patients with a total of 123 episodes (mean 1.8/patient). Death was seen in 48 (58%) patients, with 19 (23%) IRM. The majority of infections were in the gastrointestinal tract (n = 51, 30.5%), sepsis (n = 29, 17%), and respiratory tract (n = 28, 17%). Infections mostly occurred during the first induction (41%). There were 90 (73%) episodes of clinically documented infection and 33 (27%) episodes of microbiologically documented infection. The positivity rate of blood cultures was only 27%. The majority of bacteria detected were gram-negative (n = 25, 69%), and among them were Klebsiella pneumonia (19%) and Escherichia coli (19%). Candida albicans was detected in 1 (2%) culture. Suboptimal infection prevention and control were found in the clinical practice.

Conclusion: Infections and infection-related mortality in children with AML treated using the National protocol were frequent, mainly occurring during the first induction phase. Compliance with infection prevention and control measures needs improvement. Urgent attention is required for better supportive care, including isolation rooms, antibiotics, and antifungals. The predominance of Gram-negative bacterial infections highlights the necessity for further research into effective prophylaxis. Enhanced healthcare and nursing professional vigilance and tailored antibiotic strategies are vital. Improving compliance and ensuring adequate supportive care resources are essential, emphasizing nursing’s pivotal role. Further research is crucial to drive advancements in infection control strategies.

https://doi.org/10.33546/bnj.3139
PDF
XML

Copyright

Copyright (c) 2024 Eddy Supriyadi, Ignatius Purwanto, Zeni Widiastuti, Inggar Armytasari, Salsabila Sandi, Bambang Ardianto, Gertjan J. L. Kaspers

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

Ali, A. M., Weisel, D., Gao, F., Uy, G. L., Cashen, A. F., Jacoby, M. A., Wartman, L. D., Ghobadi, A., Pusic, I., & Romee, R. (2017). Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen. Cancer Medicine, 6(12), 2814-2821. https://doi.org/10.1002/cam4.1231

Ariza Heredia, E. J., & Chemaly, R. F. (2018). Update on infection control practices in cancer hospitals. CA: A Cancer Journal for Clinicians, 68(5), 340-355. https://doi.org/10.3322/caac.21462

Bochennek, K., Hassler, A., Perner, C., Gilfert, J., Schöning, S., Klingebiel, T., Reinhardt, D., Creutzig, U., & Lehrnbecher, T. (2016). Infectious complications in children with acute myeloid leukemia: Decreased mortality in multicenter trial AML-BFM 2004. Blood Cancer Journal, 6(1), e382-e382. https://doi.org/10.1038/bcj.2015.110

Central Statistical Agency. (2017). Projected Population Number According to Province and Gender (Thousand People), 2015-2017 [in Bahasa]. https://www.bps.go.id/id/statistics-table/2/MTg4NiMy/jumlah-penduduk-hasil-proyeksi-menurut-provinsi-dan-jenis-kelamin--ribu-jiwa-.html

Chong, Y., Shimoda, S., Miyake, N., Aoki, T., Ito, Y., Kamimura, T., & Shimono, N. (2017). Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis. Infection and Drug Resistance, 193-199. https://doi.org/10.2147/IDR.S133333

Creutzig, U., Zimmermann, M., Reinhardt, D., & Lehrnbecher, T. (2003). Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93. Klinische Pädiatrie, 215(3), 151-158. https://doi.org/10.1055/s-2003-39374

Davis, K., & Wilson, S. (2020). Febrile neutropenia in paediatric oncology. Paediatrics and Child Health, 30(3), 93-97. https://doi.org/10.1016/j.paed.2019.12.002

Dutta, A., & Flores, R. (2019). Infection prevention in pediatric oncology and hematopoietic stem cell transplant recipients. In J. C. McNeil, J. R. Campbell, & J. D. Crews (Eds.), Healthcare-Associated Infections in Children: A Guide to Prevention and Management (pp. 281-299). Springer International Publishing. https://doi.org/10.1007/978-3-319-98122-2_16

Dykewicz, C. A., Jaffe, H. W., & Kaplan, J. E. (2000). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients; recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. https://stacks.cdc.gov/view/cdc/13465

Faizan, M., Caniza, M. A., Anwar, S., Kashif, R.-u.-A., Saleem, R., Javed, H., Zafar, A., Taj, M. M., Hameed, A., & Homsi, M. (2020). Infection prevention and control measures at the Children Hospital Lahore: A my child matters collaborative project. JCO Global Oncology, 6, 1540-1545. https://doi.org/10.1200/GO.20.00403

Indonesia Ministry of Health. (2017). Minister of Health Regulation No. 27 concerning guidelines for infection prevention and control in health service facilities [in Bahasa]. Jakarta: Indonesia Ministry of Health Retrieved from http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._27_ttg_Pedoman_Pencegahan_dan_Pengendalian_Infeksi_di_FASYANKES_.pdf

Kalaskar, P., Anand, A., Panchal, H., Patel, A., Parikh, S., & Shah, S. (2017). A comparative study of bloodstream infections in acute myeloid leukemia according to different phases of treatment: Can we predict the organism? South Asian Journal of Cancer, 6(03), 132-133. https://doi.org/10.4103/2278-330X.214584

Kilpatrick, M., Hutchinson, A., Manias, E., & Bouchoucha, S. L. (2021). Paediatric nurses’, children's and parents’ adherence to infection prevention and control and knowledge of antimicrobial stewardship: A systematic review. American Journal of Infection Control, 49(5), 622-639. https://doi.org/10.1016/j.ajic.2020.11.025

Klein, K., van Litsenburg, R. R. L., de Haas, V., Dors, N., van den Heuvel‐Eibrink, M. M., Knops, R. R. G., Tissing, W. J. E., Versluys, B. A., Zwaan, C. M., & Kaspers, G. J. L. (2020). Causes of early death and treatment‐related death in newly diagnosed pediatric acute myeloid leukemia: recent experiences of the Dutch Childhood Oncology Group. Pediatric Blood & Cancer, 67(4), e28099. https://doi.org/10.1002/pbc.28099

Molgaard Hansen, L., Möttönen, M., Glosli, H., Jónmundsson, G. K., Abrahamsson, J., Hasle, H., Nordic Society of Paediatric, H., & Oncology. (2010). Early and treatment‐related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984–2003. British Journal of Haematology, 151(5), 447-459. https://doi.org/10.1111/j.1365-2141.2010.08389.x

Parikh, S., Goswami, P., Anand, A., Panchal, H., Patel, A., Kulkarni, R., & Shastri, B. (2018). Clinical and microbiological profile of infections during induction phase of acute myeloid leukemia. The Gulf Journal of Oncology, 1(27), 18-23.

Ruhnke, M., Arnold, R., & Gastmeier, P. (2014). Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. The Lancet Oncology, 15(13), e606-e619. https://doi.org/10.1016/S1470-2045(14)70344-4

Stoll, P., da Rocha Silla, L. M., Cola, C. M. M., Splitt, B. I., & Moreira, L. B. (2013). Effectiveness of a Protective Environment implementation for cancer patients with chemotherapy-induced neutropenia on fever and mortality incidence. American Journal of Infection Control, 41(4), 357-359. https://doi.org/10.1016/j.ajic.2012.05.018

Sung, L., Lange, B. J., Gerbing, R. B., Alonzo, T. A., & Feusner, J. (2007). Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood, The Journal of the American Society of Hematology, 110(10), 3532-3539. https://doi.org/10.1182/blood-2007-05-091942

Supriyadi, E., Purwanto, I., & Widjajanto, P. H. (2015). Implementation of adapted AML treatment in limited resources country (Indonesia National AML Protocol): Interim results. Pediatric Blood & Cancer, 62(S1), 55. https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.25505

Taj, M., Farzana, T., Shah, T., Maqsood, S., Ahmed, S. S., & Shamsi, T. S. (2015). Clinical and microbiological profile of pathogens in febrile neutropenia in hematological malignancies: A single center prospective analysis. Journal of Oncology, 2015, 596504. https://doi.org/10.1155/2015/596504

Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J. A., & Boeckh, M. J. (2009). Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: A global perspective. Bone Marrow Transplantation, 44(8), 453-455. https://doi.org/10.1038/bmt.2009.254

Zengin, E., Sarper, N., Gelen, S. A., Demirsoy, U., Karadoğan, M., Kılıç, S. Ç., Öncel, S., Arısoy, E. S., & Dündar, D. (2017). High infection-related mortality in pediatric acute myeloid leukemia without preventive antibiotics and antifungals: Retrospective cohort study of a single center from a middle-income country. Turkish Journal of Hematology, 34(4), 340-344. https://doi.org/10.4274/tjh.2017.0052